FluoSphera
Drug Discovery without animals
* Data source: Crunchbase
- Founded
- 2021
- Employees*
- 2-10
- Funding to Date*
- $1,025,000
- Website
- fluosphera.com
"We were quite disappointed by the lack of relevance of in vitro models. So we decided to create a new method, much more predictive, to improve drug discovery."
Animal models fail to predict 90% of adverse side effects. There is a strong need to develop relevant systems to better anticipate drug toxicity.
To successfully develop drugs, we need to precisely predict candidate drug metabolization, efficacy, and safety before clinical trials. FluoSphera integrates these three aspects with a systemic approach to better predict the effects of drugs before they reach the patient, thus reducing drug development failure. FluoSphera provides a more predictive alternative to animal experimentation using only human-derived tissues.
More Companies
